These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19864349)

  • 1. The swinging thyroid in hepatitis C infection and interferon therapy.
    Tran HA
    QJM; 2010 Mar; 103(3):187-91. PubMed ID: 19864349
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypes of interferon-α-induced thyroid dysfunction among patients treated for hepatitis C are associated with pretreatment serum TSH and female sex.
    Mammen JS; Ghazarian SR; Pulkstenis E; Subramanian GM; Rosen A; Ladenson PW
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3270-6. PubMed ID: 22689690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The uncertain natural history of thyrotoxic patients treated with combination interferon alfa-2beta and ribavirin.
    Tran HA
    Arch Intern Med; 2005 May; 165(9):1072; author reply 1072-3. PubMed ID: 15883255
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of interferon-alpha-induced thyroid dysfunction vary with ethnicity, sex, smoking status, and pretreatment thyrotropin in an international cohort of patients treated for hepatitis C.
    Mammen JS; Ghazarian SR; Rosen A; Ladenson PW
    Thyroid; 2013 Sep; 23(9):1151-8. PubMed ID: 23517287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormonal disturbances related to treatment of hepatitis C with interferon-alpha and ribavirin.
    Danilovic DL; Mendes-Correa MC; Chammas MC; Zambrini H; Marui S
    Clinics (Sao Paulo); 2011; 66(10):1757-63. PubMed ID: 22012048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of interferon alpha therapy with thyroid function tests in the management of hepatitis C: a case report.
    Gill G; Bajwa H; Strouhal P; Buch HN
    J Med Case Rep; 2016 Sep; 10(1):253. PubMed ID: 27632981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Side effects during interferon-alpha therapy of hepatitis C with special consideration of thyroid dysfunction].
    Obołończyk L; Obołończyk L; Siekierska-Hellmann M; Sworczak K
    Postepy Hig Med Dosw (Online); 2007 Jun; 62():309-21. PubMed ID: 18583950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyrotoxicosis induced by interferonotherapy of chronic hepatitis C in a woman with Hashimoto's thyroiditis].
    Kozielewicz D; Junik R; Halota W
    Pol Merkur Lekarski; 2014 Aug; 37(218):108-10. PubMed ID: 25252446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis.
    Wong V; Fu AX; George J; Cheung NW
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):793-8. PubMed ID: 12072050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells and other lymphocyte subpopulations in patients with melanoma developing interferon-induced thyroiditis during high-dose interferon-α2b treatment.
    Soldevila B; Alonso N; Martínez-Arconada MJ; Granada ML; Boada A; Vallejos V; Fraile M; Fernández-Sanmartín MA; Pujol-Borrell R; Puig-Domingo M; Sanmartí A; Martínez-Cáceres EM
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):621-8. PubMed ID: 22957689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural history of interferon-alpha2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infection.
    Tran HA; Reeves GE; Jones TL
    QJM; 2009 Feb; 102(2):117-22. PubMed ID: 19033352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroiditis induced by interferon in dialysis.
    Al-Harbi AS; Mansy H; Moloney J
    Saudi Med J; 2000 Jan; 21(1):96-8. PubMed ID: 11533760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFNalpha-induced recurrence of Graves' disease ten years after thyroidectomy in chronic viral hepatitis C. Case report.
    Duncea I; Pepene CE
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):453-6. PubMed ID: 19104709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C therapy is not pleasant. Patients must be prepared!].
    MMW Fortschr Med; 2003 Jan; 145(3-4):57. PubMed ID: 12619237
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C.
    Paraná R; Schinoni MI; de Freitas LA; Codes L; Cruz M; Andrade Z; Trepo C
    Liver Int; 2006 Nov; 26(9):1148-54. PubMed ID: 17032416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated interferon and ribavirin therapy for hepatitis C causing cataract.
    Ku JY; Sharma A
    Clin Exp Ophthalmol; 2009 Sep; 37(7):743-5. PubMed ID: 19788675
    [No Abstract]   [Full Text] [Related]  

  • 19. Interferon-alpha induced thyroid dysfunction: three clinical presentations and a review of the literature.
    Koh LK; Greenspan FS; Yeo PP
    Thyroid; 1997 Dec; 7(6):891-6. PubMed ID: 9459633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha induced transient thyroid dysfunction in hepatitis C.
    Fernández-Díez S; Rodríguez-Agulló JL; Cascudo Rielo MJ; Navarro Angulo N; Díaz-Rubio M
    Rev Esp Enferm Dig; 2002 Mar; 94(3):159-63. PubMed ID: 12185880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.